SCHEMBL24096902

SCHEMBL24096902

Cc1c(C(C)(C)C)noc1NC(=O)Oc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.48
ALDH1A1 P00352 8/20 0.44
MAPT P10636 2/20 0.44
FAAH O00519 1/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
KDM4E B2RXH2 1/20 0.42
THRB P10828 1/20 0.42
GFER P55789 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
EDNRA P25101 1/20 0.42
GAA P10253 2/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CYP1A2 P05177 2/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
POLB P06746 1/20 0.41
MIF P14174 1/20 0.41
RAD51 Q06609 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1011568 0.85 IDO1 (0.54) IDO1ALDH1A1MAPTMEN1KMT2A
SCHEMBL2478448 0.77 IDO1 (0.56) IDO1ALDH1A1MAPTFAAHMEN1
SCHEMBL769541 0.74 RAF1 (0.64) MAPTMEN1KMT2AHTTSMN1; SMN2
SCHEMBL2322209 0.74 ALDH1A1 (0.67) IDO1ALDH1A1MAPTMEN1KMT2A
SCHEMBL1011299 0.73 ALDH1A1 (0.44) IDO1ALDH1A1MAPTFAAHMEN1
SCHEMBL19563752 0.73 IDO1 (0.60) IDO1ALDH1A1MAPTFAAHMEN1
SCHEMBL31028574 0.73 IDO1 (0.46) IDO1ALDH1A1MAPTFAAHMEN1
SCHEMBL1013171 0.73 ALDH1A1 (0.56) IDO1ALDH1A1MAPTFAAHMEN1
SCHEMBL17736670 0.72 IDO1 (0.59) IDO1ALDH1A1MAPTMEN1KMT2A
SCHEMBL897183 0.71 RAB9A (0.61) ALDH1A1MEN1KMT2AKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230203045-A1 INHIBITORS OF NEK7 KINASE Halia Therapeutics, Inc. 2023-06-29 US disclosed
US-20230203045-A1 INHIBITORS OF NEK7 KINASE Halia Therapeutics, Inc. 2023-06-29 US disclosed
EP-4161933-A1 INHIBITORS OF NEK7 KINASE Halia Therapeutics, Inc. (US) 2023-04-12 EP disclosed
WO-2021252488-A1 INHIBITORS OF NEK7 KINASE Halia Therapeutics, Inc. (US) 2021-12-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230203045-A1 INHIBITORS OF NEK7 KINASE NEK7, NEK1, NEK5 IDO1 3259/4885ALDH1A1 4327/4885MAPT 1175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.